Globus Medical Financial Indicators Patterns

GMED -- USA Stock  

Quarterly Earning Report: November 14, 2019  

Use fundamental data analysis to validate all available fundamentals of Globus Medical to find out if markets are presently mispricing the organization. We found thirty-five available reported financial drivers for Globus Medical which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Globus Medical fundamentals including its Price to Earning, Net Income, Book Value Per Share, as well as the relationship between Revenue and Total Debt . Given that Globus Medical has Number of Shares Shorted of 2.23 M, we strongly advise you confirm Globus Medical regular market performance to make sure the company can sustain itself down the road. Use Globus Medical to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Globus Medical to be traded at $49.57 in 30 days.
43%43%

Chance of Financial Distress

Globus Medical has less than 43 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Globus Medical Company Summary

Globus Medical competes with ENCISION INC, Digirad, Second Sight, Establishment Labs, and Dynatronics. Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 1800 people.

Globus Medical Price to Earnings To Growth vs Working Capital

Globus Medical is rated # 3 in price to earnings to growth category among related companies. It is rated # 2 in working capital category among related companies reporting about  168,652,555  of Working Capital per Price to Earnings To Growth.

Globus Medical Systematic Risk

The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Globus Medical correlated with the market. If Beta is less than 0 Globus Medical generally moves in the opposite direction as compared to the market. If Globus Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Globus Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Globus Medical is generally in the same direction as the market. If Beta > 1 Globus Medical moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Globus Medical Thematic Clasifications

Obamacare Repeal Idea
Obamacare RepealView
Baby Boomer Prospects Idea
Baby Boomer ProspectsView
Medical Equipment Idea
Medical EquipmentView
Obamacare Idea
ObamacareView

Globus Medical October 15, 2019 Opportunity Range

Please also check Risk vs Return Analysis. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com